US › Healthcare

Evolent Health Inc (EVH)

US · Healthcare · Health Information Services

$3.67-1.87%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$652.5M

Revenue YoY

+46.9%

Net profit

$-28.4M

EPS

$-0.11

EPS estimate

$-0.10

Net margin

-4.3%

EPS came in at -0.11 against a street estimate of -0.10 — a miss of 10.0%.

Key statistics

Market cap

$473.7M

Forward P/E

10.0

P/B

1.24

Book value

$3.40

EPS (TTM)

$-4.49

52-week high

$9.63

52-week low

$2.10

50-day MA

$4.61

200-day MA

$3.86

Beta

0.84

Analyst view

Analysts rate Evolent Health Inc a strong buy (13 buy, 1 hold, 0 sell out of 14) with an average price target of $5.77.

Shareholding

Insiders

3.10%

Institutions

101.84%

Largest institutional holders

Fund	Stake
BlackRock Inc	9.63%
Cadian Capital Management LP	9.57%
Morgan Stanley - Brokerage Accounts	8.03%
UBS Group AG	7.21%
Rubicon Founders LLC	5.14%
Engaged Capital LLC	4.92%
D. E. Shaw & Co LP	4.52%
Vanguard Capital Management, LLC	4.31%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Evolent Health Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.